These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14693566)

  • 21. In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria.
    Yoon EJ; Jo YW; Choi SH; Lee TH; Rhee JK; Yoo M; Shim MJ; Choi EC
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2498-500. PubMed ID: 15917554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific.
    Bell JM; Turnidge JD; Ballow CH; Jones RN;
    J Antimicrob Chemother; 2003 Feb; 51(2):339-45. PubMed ID: 12562700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals.
    Reis AO; Cordeiro JC; Machado AM; Sader HS
    Braz J Infect Dis; 2001 Oct; 5(5):243-51. PubMed ID: 11779450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to emerging infection leading to outbreak of linezolid-resistant enterococci.
    Kainer MA; Devasia RA; Jones TF; Simmons BP; Melton K; Chow S; Broyles J; Moore KL; Craig AS; Schaffner W
    Emerg Infect Dis; 2007 Jul; 13(7):1024-30. PubMed ID: 18214174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
    Johnson AP; Warner M; Livermore DM
    J Antimicrob Chemother; 2002 Jul; 50(1):89-93. PubMed ID: 12096011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
    Afşar I; Barış I; Sener AG; Köksal V; Demirci M
    Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms.
    Lauterwein M; Oethinger M; Belsner K; Peters T; Marre R
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2541-3. PubMed ID: 8585741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
    J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
    Kaya O; Akcam FZ; Temel EN
    Microb Drug Resist; 2008 Jun; 14(2):151-3. PubMed ID: 18494600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
    Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of linezolid against anaerobic bacteria.
    Behra-Miellet J; Calvet L; Dubreuil L
    Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of oxazolidinone and phenicol resistant enterococcal isolates from duck feces and carcasses.
    Na SH; Moon DC; Choi MJ; Oh SJ; Jung DY; Kang HY; Hyun BH; Lim SK
    Int J Food Microbiol; 2019 Mar; 293():53-59. PubMed ID: 30640000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.
    Ford CW; Hamel JC; Wilson DM; Moerman JK; Stapert D; Yancey RJ; Hutchinson DK; Barbachyn MR; Brickner SJ
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1508-13. PubMed ID: 8726028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AM-7359--a novel oxazolidinone with low resistance potential and potent activity against drug resistant pathogens.
    Overbye KM; Mordekhay D
    J Chemother; 2007 Jun; 19(3):249-55. PubMed ID: 17594918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.